Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide is a research peptide characterized by its triple-agonist mechanism, primarily investigated in the study of metabolic signaling pathways. It simultaneously targets three key receptors: GLP-1, GIP, and glucagon receptors. This versatility of action makes it one of the most pharmacologically complex and widely studied molecules in contemporary metabolic research.
Specifications and compliance:
Form: Lyophilized powder, certified purity ≥ 99% (accompanied by a lot-specific Certificate of Analysis / COA).
Packaging: Packaging compliant with laboratory experimental standards.
Regulatory warning: Compound strictly reserved for in vitro research and laboratory use. It is not intended for human consumption, injection, or therapeutic use. Handling and storage must be carried out in accordance with safety protocols and applicable regulations.
Retatrutide is a research peptide characterized by its triple-agonist mechanism, primarily investigated in the study of metabolic signaling pathways. It simultaneously targets three key receptors: GLP-1, GIP, and glucagon receptors. This versatility of action makes it one of the most pharmacologically complex and widely studied molecules in contemporary metabolic research.
Specifications and compliance:
Form: Lyophilized powder, certified purity ≥ 99% (accompanied by a lot-specific Certificate of Analysis / COA).
Packaging: Packaging compliant with laboratory experimental standards.
Regulatory warning: Compound strictly reserved for in vitro research and laboratory use. It is not intended for human consumption, injection, or therapeutic use. Handling and storage must be carried out in accordance with safety protocols and applicable regulations.